Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 159.57B | 160.16B | 160.34B | 152.76B | 143.42B | 150.00B |
Gross Profit | 46.92B | 46.84B | 46.36B | 41.33B | 35.01B | 38.97B |
EBITDA | 6.76B | 6.59B | 6.66B | 3.84B | 2.05B | -7.22B |
Net Income | 3.51B | 3.64B | 3.62B | 1.93B | 4.40B | -7.98B |
Balance Sheet | ||||||
Total Assets | 68.91B | 66.94B | 62.42B | 59.27B | 60.98B | 57.61B |
Cash, Cash Equivalents and Short-Term Investments | 15.89B | 12.59B | 13.54B | 11.74B | 13.79B | 8.66B |
Total Debt | 7.47B | 6.81B | 8.09B | 10.12B | 13.45B | 11.73B |
Total Liabilities | 32.61B | 29.61B | 28.88B | 29.68B | 31.89B | 33.24B |
Stockholders Equity | 34.53B | 35.26B | 32.21B | 28.85B | 27.46B | 23.72B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 985.00M | 4.36B | 1.60B | 2.91B | -2.03B |
Operating Cash Flow | 0.00 | 2.81B | 5.45B | 3.09B | 4.44B | -500.00M |
Investing Cash Flow | 0.00 | -1.78B | -904.00M | -1.14B | -494.00M | -953.00M |
Financing Cash Flow | 0.00 | -1.98B | -2.75B | -3.99B | 1.18B | 4.40B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | $2.86T | 14.80 | 7.40% | 2.80% | 4.38% | 13.44% | |
69 Neutral | ¥231.77B | 14.30 | 2.61% | 6.87% | 1.26% | ||
69 Neutral | ¥26.48B | 7.27 | 10.73% | 2.21% | -0.11% | 0.75% | |
68 Neutral | ¥194.55B | 22.02 | 8.29% | 2.31% | 4.98% | 1.52% | |
67 Neutral | $1.40T | 15.51 | 7.61% | 2.65% | 3.98% | 0.28% | |
64 Neutral | $548.71B | 100.35 | 2.87% | 0.74% | 2.69% | -47.13% | |
63 Neutral | $1.60T | 28.24 | 4.91% | 3.75% | 9.00% | -57.41% |